Position in DXCM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$786,715
+$53,149 QoQ
Shares Held
11,681
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#511
of 966 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Plato Investment Management Ltd holds $17,212,974 across 10 Medical Devices names. DXCM ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
44,606 | $4,047,548 | |
| 2 | SYK |
Stryker Corp
|
12,092 | $3,807,045 | |
| 3 | MDT |
Medtronic plc
|
46,948 | $3,672,742 | |
| 4 | EW |
Edwards Lifesciences Corp
|
22,627 | $2,046,838 | |
| 5 | BSX |
Boston Scientific Corp
|
30,788 | $1,314,031 | |
| 6 | STE |
STERIS plc
|
4,026 | $847,754 | |
| 7 | DXCM |
Dexcom Inc
This page
|
11,681 | $786,715 | |
| 8 | PODD |
Insulet Corp
|
2,356 | $358,701 |
All Filings in DXCM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $786,715 | 11,681 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $733,566 | 11,681 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $953,338 | 14,364 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $966,553 | 14,364 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,249,992 | 14,320 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $977,707 | 14,317 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $1,204,890 | 15,493 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $509,705 | 7,603 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,519,858 | 13,405 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,908,928 | 13,763 | Shares | Sole | 2024-05-17 | |
| 2023-12-31 | $299,925 | 2,417 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||